loader2
Partner With Us NRI

Global Health Ltd share Price Today

Company details

1,166.85
1,205.00
655.65
1,513.90
6M Return 18.20%
1Y Return 69.58%
Mkt Cap.(Cr) 31,584.48
Volume 222,479
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 222,479

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Healthcare Facilities company Global Health announced consolidated Q4FY24 & FY24 results:

FY24 Financial Highlights:

  • Total income of Rs 33,498 million, growth of 21% YoY
  • EBITDA of Rs 8,737 million compared to Rs 6,771 million, growth of 29% YoY
  • EBITDA margins improved by 154 bps to 26.1%
  • Profit after tax of Rs 4,781 million, growth of 47% YoY
  • Net cash surplus of Rs 7,720 million
  • Average occupied bed days increased by 14% YoY, representing an occupancy of 62% on increased bed capacity
  • In-patients count increased by 15%; Out-patient count increased by 18% in FY24
  • ARPOB grew by 4.7% to Rs 61,890
  • Developing hospitals revenue share of consolidated revenue increased from 27% in FY23 to 30% in FY24 amounting to Rs 9,948 million. Developing hospital EBITDA share of consolidated EBITDA increased from 32% in FY23 to 37% in FY24 amounting to Rs 3,208 million
  • During the period, International Patients Revenue increased by 24% to Rs 1,935 million, driven by increased volume in international patient admissions and higher realizations
  • In house OPD Pharmacy business continues to register strong growth. Revenue increased by 32% from Rs 850 million in FY23 to Rs 1,121 million in FY24

Q4FY24 Financial Highlights:

  • Total income of Rs 8,361 million; growth of 14% YoY
  • EBITDA of Rs 2,068 million; growth of 8% YoY
  • EBITDA margins remained stable at 24.7%
  • Profit after tax of Rs 1,273 million; growth of 26% YoY
  • Average occupied bed days increased by 9% YoY, representing an occupancy of 59% on increased bed capacity
  • ARPOB grew by 4% to Rs 63,063; In-patient count increased by 10% YoY; Out-patient count increased by 11% YoY

Commenting on FY2024 results, Pankaj Sahni, Group CEO and Director said: “I am pleased to inform that keeping with our consistent focus on quality care, Medanta has been recognized by Newsweek as India's 'Best Private Hospital' for the fifth consecutive year. Medanta Gurugram is also the only Indian private hospital to feature in the top 200 hospitals in the world.

The continued focus on providing our patients with the highest quality of care has enabled Medanta to deliver strong financial results during the year. We remain dedicated to executing our core strategy and delivering on our upcoming projects. Medanta is well-positioned to drive near-term growth with calibrated bed capacity expansions at existing hospitals and new facilities.”

Result PDF

View Other Company Results

Global Health Ltd shares SWOT Analysis

Strengths (11)

  • Company with high TTM EPS Growth
  • Effectively using its capital to generate profit - RoCE improving in last 2 years
  • Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Weakness (2)

  • Declining Revenue every quarter for the past 2 quarters
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (0)

Data not found

Threats (3)

  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income
  • RSI indicating price weakness

Resistance and support

R1 1,198.6
R2 1,220.9
R3 1,236.7
Pivot

1,182.72

S1 1,160.4
S2 1,144.6
S3 1,122.3
EMA SMA
1,235.4
1,263.0
1,248.7
1,135.5
1,247.8
1,262.3
1,301.4
1,142.4
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
JM FINANCIAL INSTITUTIONAL SECURITIES LIMITED Bulk Purchase 2024-02-14 1315.22 3000000 BSE
RJ CORP LIMITED Bulk Purchase 2024-02-14 1315 2882203 BSE
JM FINANCIAL INSTITUTIONAL SECURITIES LIMITED Bulk Sell 2024-02-14 1315.05 3000000 BSE
Name Category Shares
NARESH TREHAN PROMOTER 33.04%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Global Health Ltd Stocks COMPARISON

Financials( in Cr) Global Health Ltd Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Fortis Healthcare Ltd Syngene International Ltd
Price 1,176.30 6,403.60 935.10 487.20 757.75
% Change -6.07 0.44 3.04 3.64 1.77
Mcap Cr 31,584.48 92,074.16 90,883.49 36,781.55 30,502.24
Revenue TTM Cr 2,280.01 16,612.50 4,831.37 7,175.67 3,488.60
Net Profit TTM Cr 360.89 887.50 1,103.51 645.22 510.00
PE TTM 66.14 102.66 85.96 63.06 58.53
1 Year Return 69.58 24.14 52.63 51.00 0.03
ROCE 17.19 14.16 13.85 9.65 13.56
ROE 13.52 15.04 16.12 7.81 12.95
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 2,848.80 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 8,306.88 53,539.14
LAST 3M 89,013.52 64,904.32
LAST 6M 176,751.92 63,807.63
LAST 12M 305,416.58 96,213.98

Global Health Ltd Information

Stock PE (TTM)
66.14
Promoter Holding
33.04%
Book Value
108.1984
ROCE
17.19%
ROE
13.52%
Description
  • Global Health Limited (GHL) was incorporated as `Global Health Private Limited` on August 13, 2004 at New Delhi, India as a Private Limited Company. The Company converted into a Public Limited Company and name of the Company was changed to `Global Health Limited` dated August 11, 2021 issued by the RoC. Presently, the Company is engaged in the business of providing healthcare services. The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon. The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly. Under the "Medanta" brand, it has a network of 5 hospitals currently in operation including, Gurugram, Indore, Ranchi, Lucknow and Patna and one hospital in Noida, which is under construction. As at June 30, 2022, the Company provide healthcare services in over 30 medical specialties and is engaged over 1,300 doctors led by experienced department heads and, spanning an area of 4.7 million sq. ft., their operational hospitals have 2,467 installed beds to serve Indian and international patients. In November 2009, the Company opened its flagship hospital in Gurugram. In 2015, its subsidiary, Global Health Patliputra Private Limite (GHPPL), entered into a Concession Agreement with Governor of Bihar for the development, operation and maintenance of a proposed hospital on public-private partnership at Patna. In 2019, it commenced operations of new hospital at Lucknow. In 2020, Patna hospital`s outpatient department facility was launched and the inpatient department facility of its Patna hospital was inaugurated in October 2021, which commenced operations during year 2022. The Company has taken in-house facility and operate pharmacies at its Gurugram, Lucknow, Indore and Ranchi hospitals as well as launched an outpatient department pharmacy at South Delhi clinic in year 2021 and launched outpatient department pharmacy at South Delhi clinic at Patna hospital in year 2022. As at June 30, 2022, it had 200 installed beds and employed over 50 doctors across key specialties such as neuroscience and cardiac sciences. Patna hospital had 228 installed beds and employed over 125 doctors as at June 30, 2022 and is designed to accommodate over 500 beds. In the Board Meeting dated 25 January 2021, the Board of Directors of the Holding Company have approved capital raising comprising of fresh issue and offer for sale of equity shares by the existing shareholders through an Initial Public Offering (IPO) The Company came out with a public issue during November, 2022 by raising Rs. 2205.57 crores through fresh issue amounting to Rs. 500 crores and offer for sale amounting to Rs. 1705.57 crores. The Company`s Lucknow hospital added 191 beds in FY23, including over 90 critical care beds. Lucknow Hospital further added 7 new OTs and have hired over 50 senior clinicians. Towards the end of FY 2023, Lucknow Hospital commissioned the Siemens Varian EDGE Radiation Oncology machine - the first in North India - as well as set up a dedicated e-ICU Command Centre to assist in remote critical care management. The Company`s Patna hospital added over 100 beds and 35 doctors in FY23. In FY23, the Company introduced a new 300- bed hospital project in Indore. It started Medanta Labs in January 2023. During the year 2022-23, GHL Pharma was incorporated as a wholly-owned subsidiary on June 29, 2022.

Registered Address

Medanta-Mediclinic, E-18 Defence Colony, New Delhi, New Delhi, 110024

Tel : 91-124-4834060
Email : compliance:medanta.org
Website : http://www.medanta.org
Registrar

KFin Techologies Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 543654
NSE Code : MEDANTA
Book Closure Date (Month) :
BSE Group : A
ISIN : INE474Q01031

FAQ’s on Global Health Ltd Shares

You can buy Global Health Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Global Health Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 23, 2024 04:04 PM the closing price of Global Health Ltd was Rs.1,176.30.

The latest PE ratio of Global Health Ltd as of Jul 23, 2024 04:04 PM is 66.14

The latest PB ratio of Global Health Ltd as of Jul 23, 2024 04:04 PM is 0.09

The 52-week high of Global Health Ltd share price is Rs. 1,513.90 while the 52-week low is Rs. 655.65

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 23, 2024 04:04 PM, the market cap of Global Health Ltd stood at Rs. 31,584.48 Cr.

Download App

Download Our App

Play Store App Store
market app